Abnormalities in micturition: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 11: Line 11:
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! colspan="3" rowspan="5" |Diseases
! colspan="3" rowspan="5" |Diseases
| rowspan="5" |Type of hematuria
| colspan="8" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations'''
| colspan="9" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations'''
! colspan="6" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings
! colspan="9" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings
| colspan="1" rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
| colspan="1" rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
|-
|-
| colspan="6" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms'''
| colspan="5" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms'''
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination
|-
|-
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
|-
|-
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Low back pain
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Low back pain
! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nausea/Vomiting
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urinary symptoms
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urinary symptoms
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hypertension
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Supra-pubic tenderness
! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pitting edema
! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin lesions
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |CBC
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |CBC
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Biomarkers
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Electrolytes
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urinalysis
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urinalysis
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Ultrasonography
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Ultrasonography
Line 38: Line 35:
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
|-
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysuria
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dribbling
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Frequency
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hesitancy
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Oliguria
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nocturia
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Light microscopy
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Electron microscopy
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunoflourescence pattern
|-
|-
! rowspan="10" |[[Inflammatory]]
! rowspan="3" |[[Dermatological lesions|Dermatological disorders]]
![[Lichen sclerosus]]
!
!
!
!
Line 53: Line 50:
!
!
!
!
!
!
!
!
!
!
!
!
|-
![[Behcet's syndrome]]
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
![[Contact dermatitis]]
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
! rowspan="7" |[[Infectious disease|Infectious diseases]]
![[Cystitis]]
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
![[Urethritis]]
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
![[Pyelonephritis]]
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
![[Vulvovaginitis]]
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
![[Cervicitis]]
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
![[Prostatitis]]
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
![[Epididymoorchitis]]
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
! rowspan="11" |Non-[[inflammatory]]
! rowspan="2" |[[Anatomic]]
![[Urethral stricture]]
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
![[Benign prostatic hyperplasia|Benign prostatic hyperplasia (BPH)]]
!
!
!
!
Line 70: Line 260:
!
!
|-
|-
! rowspan="2" |[[Drug]]
![[Spermicide|Spermicides]]
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
![[Cyclophosphamide]]
!
!
!
!
!
!
!
!
!
!
!
!
Line 78: Line 296:
!
!
!
!
|-
! rowspan="2" |[[Endocrine disorders]]
![[Atrophic vaginitis]]
!
!
!
!
Line 95: Line 316:
!
!
|-
|-
![[Endometriosis]]
!
!
!
!
!
!
!
!
!
Line 103: Line 330:
!
!
!
!
!
!
!
|-
! rowspan="2" |[[Malignancy]]
![[Bladder cancer]]
!
!
!
!
Line 120: Line 353:
!
!
|-
|-
![[Vulvovaginal disorders|Vulvovaginal cancer]]
!
!
!
!
Line 128: Line 362:
!
!
!
!
!
!
!
!
!
!
!
!
|-
! rowspan="3" |[[Iatrogenic]]
![[Genitourinary system|Genitourinary instrumentation]]
!
!
!
!
Line 145: Line 390:
!
!
|-
|-
![[Pelvic]] [[irradiation]]
!
!
!
!
!
!
!
!
!
Line 153: Line 404:
!
!
!
!
!
!
!
|-
![[Trauma]]
!
!
!
!

Revision as of 18:36, 16 May 2018

Micturation Abnormalities Microchapters

Overview

Causes

Differential Diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Overview

Classification

Causes

Abnormalities of Micturation Differential Diagnosis

Differentiating the diseases that can cause abnormality in micturation:

Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
Symptoms Physical examination
Lab Findings Imaging
Low back pain Fever Urinary symptoms Supra-pubic tenderness Skin lesions Other CBC Electrolytes Urinalysis Ultrasonography CT scan Other
Dribbling Hesitancy Nocturia
Inflammatory Dermatological disorders Lichen sclerosus
Behcet's syndrome
Contact dermatitis
Infectious diseases Cystitis
Urethritis
Pyelonephritis
Vulvovaginitis
Cervicitis
Prostatitis
Epididymoorchitis
Non-inflammatory Anatomic Urethral stricture
Benign prostatic hyperplasia (BPH)
Drug Spermicides
Cyclophosphamide
Endocrine disorders Atrophic vaginitis
Endometriosis
Malignancy Bladder cancer
Vulvovaginal cancer
Iatrogenic Genitourinary instrumentation
Pelvic irradiation
Trauma
Retrieved from "https://www.wikidoc.org/index.php?title=Abnormalities_in_micturition&oldid=1471374"